Morgan Stanley Maintains Equal-Weight on Accolade, Lowers Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Equal-Weight rating on Accolade (NASDAQ:ACCD) but lowers the price target from $12 to $6.

June 28, 2024 | 3:51 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Accolade but significantly lowered the price target from $12 to $6, indicating a cautious outlook.
The significant reduction in the price target from $12 to $6 by a major financial institution like Morgan Stanley suggests a more cautious outlook on Accolade's future performance. This is likely to negatively impact the stock price in the short term as investors may adjust their expectations accordingly.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100